MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Ptprcltng/Ptprctm1Mak,Tg(TcraTcrb)425Cbn/0 Genetic Background: involves: 129/Sv * BALB/c * C57BL/6
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pcgf2tm1Hko/Pcgf2tm1Hko,Bmi1tm1Brn/Bmi1tm1Brn Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Irf3tm1Ttg/Irf3tm1Ttg,Irf7tm1Ttg/Irf7tm1Ttg Genetic Background: involves: 129P2/OlaHsd * 129S/SvEv
Allelic Composition: Irf7tm1Ttg/Irf7tm1Ttg Genetic Background: B6.129P2-Irf7tm1Ttg
|
MP:0002444 | abnormal T cell physiology | "anomalous response of T lymphocytes" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pcgf2tm1Hko/Pcgf2tm1Hko,Bmi1tm1Brn/Bmi1tm1Brn Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0008563 | decreased interferon-alpha secretion | "increase in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Gpr149tm1.1Zuk/Gpr149+ Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J * FVB/N
Allelic Composition: Irf7m1Btlr/Irf7+ Genetic Background: C57BL/6J-Irf7m1Btlr
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Irf3tm1Ttg/Irf3tm1Ttg,Irf7tm1Ttg/Irf7tm1Ttg Genetic Background: involves: 129P2/OlaHsd * 129S/SvEv
Allelic Composition: Irf7m1Btlr/Irf7m1Btlr Genetic Background: C57BL/6J-Irf7m1Btlr
Allelic Composition: Irf7m1Btlr/Irf7+ Genetic Background: C57BL/6J-Irf7m1Btlr
|
MP:0008576 | decreased circulating interferon-beta level | "reduction in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Dclre1cm1Btlr/Dclre1cm1Btlr Genetic Background: C57BL/6J-Dclre1cm1Btlr
Allelic Composition: Irf7M2Btlr/Irf7+ Genetic Background: C57BL/6J-Irf7M2Btlr
|
MP:0008658 | decreased interleukin-1 beta secretion | "reduction in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Irf3tm1Ttg/Irf3tm1Ttg,Irf7tm1Ttg/Irf7tm1Ttg Genetic Background: involves: 129P2/OlaHsd * 129S/SvEv
|
MP:0008750 | abnormal interferon level | "deviation from the normal levels of proteins secreted by vertebrate cells in response to a wide variety of inducers; they confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions" [MESH:D12.644.276.374.440] |
Show
Allelic Composition: Pcgf2tm1Hko/Pcgf2tm1Hko,Bmi1tm1Brn/Bmi1tm1Brn Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0009791 | increased susceptibility to viral infection induced morbidity/mortality | "increased likelihood that an organism will display the expected moribund state caused by a viral invasion or from components of or toxins produced by a virus" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Irf7tm1Ttg/Irf7tm1Ttg Genetic Background: B6.129P2-Irf7tm1Ttg
|